You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 8, 2025

Details for Patent: 4,801,587


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,801,587
Title: Impotence ointment
Abstract:An ointment for relieving impotence. The ointment generally consists of a primary agent, a carrier, and a base, and is applied directly to the penis. The primary agent is a vasodilator selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine. The carrier is used to assist absorption of the primary agent through the skin around the penis. When the primary agent enters the corpora cavernosa within the penis, it causes dilation of the corpora, resulting in an erection.
Inventor(s): Voss; Gene (San Antonio, TX), Eichler; Allen C. (San Antonio, TX)
Assignee:
Application Number:07/020,544
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 4,801,587: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,801,587, titled "Impotence ointment," was granted for an invention related to a topical ointment designed to relieve impotence. This analysis will delve into the scope and claims of the patent, as well as the broader patent landscape surrounding this technology.

Scope of the Patent

The patent describes an ointment composed of a primary agent, a carrier, and a base, applied directly to the penis to relieve impotence. Here are the key components of the scope:

Primary Agent

The primary agent is the active ingredient responsible for the therapeutic effect. The patent does not specify a particular compound but outlines the necessity of an agent that can effectively address impotence[2].

Carrier and Base

The carrier and base are inert ingredients that facilitate the application and stability of the primary agent. The choice of these components is crucial for the ointment's efficacy and user comfort[2].

Claims of the Patent

The claims section of the patent outlines the specific aspects of the invention that are protected by law. Here are the key claims:

Composition Claims

The patent claims the specific composition of the ointment, including the combination of the primary agent, carrier, and base. These claims ensure that any similar ointment must differ significantly to avoid infringement[2].

Method of Application Claims

The patent also claims the method of applying the ointment directly to the penis, which is a critical aspect of its therapeutic effectiveness[2].

Patent Landscape Analysis

To understand the broader context of this patent, a patent landscape analysis is essential. Here are the key steps and insights:

Define Scope and Keywords

The analysis begins by defining the technology field, which in this case is topical treatments for impotence. Relevant keywords include "impotence ointment," "topical treatment for erectile dysfunction," and "male sexual health products"[3].

Search and Organize Patents

Using databases such as the USPTO's Patent Public Search, European Patent Office's esp@cenet, and other international patent databases, relevant patents are identified and organized. This includes categorizing patents by filing date, assignee, and technology subcategories[1][3].

Identify Trends and Key Players

The analysis reveals trends in patent filings related to impotence treatments. Key players in this field include pharmaceutical companies and research institutions that have been actively filing patents for similar or related inventions. For example, companies like Vivus Inc. have developed and patented methods and compositions for enhancing sexual desire and responsiveness[5].

Analyze Citations and Evolution

Studying how patents reference each other helps in understanding the impact and development of the technology. The Common Citation Document (CCD) application can be used to consolidate prior art cited by multiple offices, providing a comprehensive view of the patent family and its evolution[1].

Generate Insights for Decisions

The analysis translates into practical guidance for strategic decisions. It helps in evaluating the competitive landscape, identifying potential legal vulnerabilities, and understanding the strength of the patent portfolio. For instance, knowing the key players and their patent portfolios can inform decisions about licensing, collaboration, or further innovation[3].

Competitive Landscape

The competitive landscape for impotence treatments is dynamic, with various pharmaceutical and biotechnology companies actively developing new treatments. Here are some insights:

Existing Treatments

Besides topical ointments, other treatments for impotence include oral medications like sildenafil (Viagra), injectable treatments, and surgical options. The patent landscape shows a mix of these approaches, each with its own set of patents and innovations[3].

Emerging Trends

There is a growing interest in natural and alternative treatments for impotence, which is reflected in recent patent filings. This trend indicates a shift towards more holistic and less invasive solutions, which could impact the market for traditional treatments[3].

Legal Vulnerabilities

Understanding the legal landscape is crucial for maintaining the validity and enforceability of the patent. Here are some considerations:

Prior Art

Ensuring that the invention is novel and non-obvious over prior art is essential. The Patent Public Search and other international databases help in identifying prior art that could challenge the patent's validity[1].

Office Actions

The Global Dossier and Office Action Indicators can help identify applications that contain office actions, which can provide insights into potential legal challenges and how to address them[1].

Conclusion

United States Patent 4,801,587 for an impotence ointment is part of a broader landscape of treatments for male sexual health issues. Understanding the scope and claims of this patent, as well as the competitive and legal landscape, is crucial for inventors, researchers, and businesses operating in this field.

Key Takeaways

  • Scope and Claims: The patent covers a specific composition and method of application for an impotence ointment.
  • Patent Landscape: The analysis involves defining the scope, searching and organizing patents, identifying trends and key players, analyzing citations, and generating insights for strategic decisions.
  • Competitive Landscape: The field includes various treatments such as oral medications, injectables, and surgical options, with emerging trends towards natural and alternative solutions.
  • Legal Vulnerabilities: Ensuring novelty and non-obviousness over prior art and addressing office actions are critical for maintaining patent validity.

FAQs

What is the primary purpose of United States Patent 4,801,587?

The primary purpose of this patent is to describe and protect an ointment designed to relieve impotence through topical application.

How can one conduct a patent landscape analysis for this technology?

A patent landscape analysis involves defining the scope, searching and organizing relevant patents, identifying trends and key players, analyzing citations, and generating insights for strategic decisions.

What are some of the key players in the field of impotence treatments?

Key players include pharmaceutical companies like Vivus Inc. and other research institutions actively filing patents for related inventions.

What are the potential legal vulnerabilities for this patent?

Potential legal vulnerabilities include challenges based on prior art and office actions, which can be identified and addressed through thorough patent searches and analysis.

How does the patent landscape impact business decisions in this field?

The patent landscape provides insights into technological trends, key players, and potential legal vulnerabilities, helping businesses make informed decisions about innovation, licensing, and collaboration.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,801,587

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,801,587

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1320442 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.